Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05054699 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

Study acronym: EMCODE
StatusCompleted
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Primary completion pushed from Jan 15, 2026 to Jun 30, 2026 · Eligibility criteria expanded, about 10 words · Secondary endpoints: details revised at 3 of 3 entries · 1 more Show 4 more changesShow less
    • Primary completion pushed from Jan 15, 2026 to Jun 30, 2026
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Publications: details revised at 1 of 1 entry
  2. Primary completion date changed from estimate of Jun 1, 2024 to Jan 15, 2026 Trial status: Recruiting to Active, Not Recruiting · Completion date: Jun 1, 2025 to Jun 30, 2026 · Site details revised · 1 morev2 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Jun 1, 2025 to Jun 30, 2026
    • Site details revised
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to compare the efficacy and safety profile of Magnetic Seizure Therapy and Electroconvulsive therapy.
Trial Details
NCT Number NCT05054699
Lead Sponsor University of Sao Paulo
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions Major Depressive Disorder, Bipolar Depression
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov